112 related articles for article (PubMed ID: 8571316)
1. Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia.
Greinacher A; Alban S; Dummel V; Franz G; Mueller-Eckhardt C
Thromb Haemost; 1995 Sep; 74(3):886-92. PubMed ID: 8571316
[TBL] [Abstract][Full Text] [Related]
2. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.
Greinacher A; Pötzsch B; Amiral J; Dummel V; Eichner A; Mueller-Eckhardt C
Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407
[TBL] [Abstract][Full Text] [Related]
3. Heparin-associated thrombocytopenia: the antibody is not heparin specific.
Greinacher A; Michels I; Mueller-Eckhardt C
Thromb Haemost; 1992 May; 67(5):545-9. PubMed ID: 1325681
[TBL] [Abstract][Full Text] [Related]
4. Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation--a possible new indication for high dose i.v. IgG.
Greinacher A; Liebenhoff U; Kiefel V; Presek P; Mueller-Eckhardt C
Thromb Haemost; 1994 May; 71(5):641-5. PubMed ID: 8091393
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
7. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.
Fritzsche J; Alban S; Ludwig RJ; Rubant S; Boehncke WH; Schumacher G; Bendas G
Biochem Pharmacol; 2006 Aug; 72(4):474-85. PubMed ID: 16780802
[TBL] [Abstract][Full Text] [Related]
8. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia.
Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
[TBL] [Abstract][Full Text] [Related]
10. Newer insights on the mechanism of heparin-induced thrombocytopenia.
Walenga JM; Jeske WP; Prechel MM; Bakhos M
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():57-67. PubMed ID: 15085467
[TBL] [Abstract][Full Text] [Related]
11. Antigens involved in heparin-induced thrombocytopenia.
Amiral J
Semin Hematol; 1999 Jan; 36(1 Suppl 1):7-11. PubMed ID: 9930557
[TBL] [Abstract][Full Text] [Related]
12. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
13. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
Amiral J; Peynaud-Debayle E; Wolf M; Bridey F; Vissac AM; Meyer D
Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647
[TBL] [Abstract][Full Text] [Related]
14. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
15. [Thrombopenia induced by heparin. From physiopathology to treatment].
Gruel Y
Ann Med Interne (Paris); 1997; 148(2):136-41. PubMed ID: 9238438
[TBL] [Abstract][Full Text] [Related]
16. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.
Selleng K; Warkentin TE; Sheppard JA; Greinacher A
Transfusion; 2009 Sep; 49(9):1812-8. PubMed ID: 19497062
[TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia: an overview.
Kelton JG
Blood Rev; 2002 Mar; 16(1):77-80. PubMed ID: 11914002
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia.
Warkentin TE
Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia: a review.
Girolami B; Girolami A
Semin Thromb Hemost; 2006 Nov; 32(8):803-9. PubMed ID: 17171593
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia.
Chong BH; Eisbacher M
Semin Hematol; 1998 Oct; 35(4 Suppl 5):3-8; discussion 35-6. PubMed ID: 9855178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
